Posted by Michael Wonder on 24 Sep 2025
PHARMAC proposes funding five medicines and more convenient treatment options to ease pressure on health services
24 September 2025 - New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer could benefit from five medicines proposed for funding by PHARMAC.
Pharmac is consulting on a multi-product agreement with Roche that includes new treatments and faster to administer types of existing medicines. If approved, the medicines would be funded from 1 December 2025.
